131 related articles for article (PubMed ID: 7878834)
21. CD8+ T-cell removal reduces survival of minor antigen mismatched islet allografts (CBA-->C3H) in mice treated with anti-CD4 monoclonal antibody.
Koulmanda M; Mandel TE
Transplant Proc; 1992 Oct; 24(5):2297-8. PubMed ID: 1413065
[No Abstract] [Full Text] [Related]
22. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
[TBL] [Abstract][Full Text] [Related]
23. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
Chen BG; Liu Z; Wu Y
Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness.
Saitovitch D; Bushell A; Mabbs DW; Morris PJ; Wood KJ
Transplantation; 1996 Jun; 61(11):1642-7. PubMed ID: 8669111
[TBL] [Abstract][Full Text] [Related]
25. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
Isobe M; Suzuki J; Yamazaki S; Sekiguchi M
Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
[No Abstract] [Full Text] [Related]
26. Intrathymic injection of anti-Fas monoclonal antibody prolongs murine non-vascularized cardiac allograft survival.
Djamali A; Waller KR; McAnulty J; Hullett D; Becker BN; Odorico JS
Transpl Int; 2004 Jul; 17(6):301-9. PubMed ID: 15205723
[TBL] [Abstract][Full Text] [Related]
27. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies.
Stepkowski SM; Tu Y; Condon TP; Bennett CF
Transplant Proc; 1995 Feb; 27(1):113. PubMed ID: 7878822
[No Abstract] [Full Text] [Related]
28. Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies.
Chen Z; Cobbold SP; Waldmann H; Metcalfe SM
Transplant Proc; 1994 Jun; 26(3):1199-200. PubMed ID: 8029885
[No Abstract] [Full Text] [Related]
29. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
30. Nondepleting anti-CD4 antibodies in transplantation. Evidence that modulation is far less effective than prolonged CD4 blockade.
Darby CR; Bushell A; Morris PJ; Wood KJ
Transplantation; 1994 May; 57(10):1419-26. PubMed ID: 8197600
[TBL] [Abstract][Full Text] [Related]
31. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM
Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
[No Abstract] [Full Text] [Related]
32. Intrathymic tolerance induction is based on suppressor cells.
Kampinga J; Klatter F; Bartels H; Pater J; Nieuwenhuis P; Roser B; Groen H
Transplant Proc; 1994 Apr; 26(2):725-6. PubMed ID: 8171626
[No Abstract] [Full Text] [Related]
33. Effect of recipient T cell subset depletion on graft coronary arteriosclerosis induction in the rat retransplant model.
Izutani H; Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Nakata S; Matsuda H
Transplant Proc; 1996 Jun; 28(3):1828-9. PubMed ID: 8658903
[No Abstract] [Full Text] [Related]
34. Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.
Noort WA; Benner R; Savelkoul HF
Transplant Proc; 1995 Feb; 27(1):384-6. PubMed ID: 7879030
[No Abstract] [Full Text] [Related]
35. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
[TBL] [Abstract][Full Text] [Related]
36. Specific unresponsiveness in rats with prolonged allograft survival is dependent upon the graft and suppressor T cells.
Hall BM; Gurley K; Dorsch SE
Transplant Proc; 1987 Feb; 19(1 Pt 1):495-6. PubMed ID: 2978915
[No Abstract] [Full Text] [Related]
37. Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4(+) regulatory T cells.
Niimi M; Ikeda Y; Shirasugi N; Shatari T; Takami H; Kodaira S; Matsumoto K; Hamano K; Esato K; Hara M; Wood KJ
Transplant Proc; 2000 Nov; 32(7):2035. PubMed ID: 11120054
[No Abstract] [Full Text] [Related]
38. Combined CTLA4Ig and anti-CD4/DC8 monoclonal antibody treatment prolongs survival of rat-to-mouse heterotopic cardiac xenografts.
Rehman A; Tu Y; Flye MW
Transplant Proc; 1996 Apr; 28(2):660-1. PubMed ID: 8623331
[No Abstract] [Full Text] [Related]
39. The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival.
Sablinski T; Sayegh MH; Kut JP; Tilney NL; Milford EL; Kupiec-Weglinski JW
Transplantation; 1992 Jan; 53(1):219-21. PubMed ID: 1346346
[No Abstract] [Full Text] [Related]
40. Functional analysis of donor-reactive T cells infiltrating heterotopic cardiac transplants: effect of anti-CD4 MAb in vivo.
Bishop DK; Shelby J; Eichwald EJ
Transplant Proc; 1991 Feb; 23(1 Pt 1):287-9. PubMed ID: 1990534
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
